Core Viewpoint - Investors in the Medical - Drugs sector should consider Grifols (GRFS) and Stevanato Group (STVN) for potential value opportunities [1] Group 1: Zacks Rank and Earnings Outlook - Grifols has a Zacks Rank of 2 (Buy), indicating a stronger earnings outlook compared to Stevanato Group, which has a Zacks Rank of 3 (Hold) [3] - The Zacks Rank strategy focuses on companies with positive earnings estimate revision trends, which is a key consideration for value investors [2] Group 2: Valuation Metrics - Grifols has a forward P/E ratio of 8.39, significantly lower than Stevanato Group's forward P/E of 39.52, suggesting that GRFS may be undervalued [5] - The PEG ratio for Grifols is 0.29, indicating a favorable valuation relative to its expected earnings growth, while Stevanato Group has a PEG ratio of 2.13 [5] - Grifols also has a P/B ratio of 0.65, compared to Stevanato Group's P/B of 4.51, further highlighting the relative undervaluation of GRFS [6] Group 3: Overall Value Assessment - Grifols earns a Value grade of A, while Stevanato Group receives a Value grade of C, indicating that GRFS is viewed more favorably by value investors [6] - The combination of Zacks Rank and Style Scores suggests that Grifols is the better investment option at this time [6]

Core Viewpoint - Investors in the Electronics - Miscellaneous Products sector should consider Flex (FLEX) and Garmin (GRMN) for potential value investment opportunities [1] Valuation Metrics - FLEX has a forward P/E ratio of 14.55, while GRMN has a forward P/E of 25.58 [5] - FLEX's PEG ratio is 1.61, compared to GRMN's PEG ratio of 2.29 [5] - FLEX's P/B ratio is 3.24, whereas GRMN's P/B ratio is 4.78 [6] Analyst Outlook - FLEX currently holds a Zacks Rank of 2 (Buy), indicating a more favorable earnings estimate revision activity compared to Garmin, which has a Zacks Rank of 3 (Hold) [3][6] - FLEX's stronger estimate revision activity and more attractive valuation metrics suggest it is the superior option for value investors at this time [7] Value Grades - FLEX has a Value grade of A, while GRMN has a Value grade of D, reflecting the relative attractiveness of their valuations [6]

Core Insights - TTEC Holdings (TTEC) is currently more attractive to value investors compared to MeridianLink (MLNK) based on various financial metrics and rankings [1][3][7] Valuation Metrics - TTEC has a forward P/E ratio of 4.39, significantly lower than MLNK's forward P/E of 47.24, indicating TTEC is undervalued [5] - TTEC's PEG ratio stands at 0.26, while MLNK's PEG ratio is 1.59, suggesting TTEC has better growth potential relative to its price [5] - TTEC's P/B ratio is 0.83, compared to MLNK's P/B of 2.98, further highlighting TTEC's undervaluation [6] Earnings Estimates - TTEC holds a Zacks Rank of 2 (Buy), indicating positive earnings estimate revisions, while MLNK has a Zacks Rank of 3 (Hold) [3][7] - The stronger estimate revision activity for TTEC suggests an improving earnings outlook compared to MLNK [7] Value Grades - TTEC has been assigned a Value grade of B, while MLNK has a Value grade of D, reflecting TTEC's more favorable valuation metrics [6]

Core Viewpoint - The comparison between Continental AG (CTTAY) and Ferrari (RACE) indicates that CTTAY is currently the more attractive option for value investors based on various valuation metrics [1][7]. Valuation Metrics - CTTAY has a forward P/E ratio of 9.70, while RACE has a significantly higher forward P/E of 49.87 [5]. - The PEG ratio for CTTAY is 0.72, indicating it is undervalued relative to its expected earnings growth, whereas RACE has a PEG ratio of 5.61, suggesting it is overvalued [5]. - CTTAY's P/B ratio stands at 1.13, compared to RACE's P/B ratio of 30.81, further highlighting CTTAY's relative undervaluation [6]. Earnings Outlook - Both CTTAY and RACE have a Zacks Rank of 2 (Buy), indicating a positive earnings outlook due to favorable analyst estimate revisions [3]. - Despite both companies having solid earnings prospects, the valuation metrics suggest that CTTAY is the superior value option at this time [7].

Company Overview - Novo Nordisk (NVO) is headquartered in Bagsvaerd and operates in the Medical sector [3] - The stock has experienced a price decline of 16.88% since the beginning of the year [3] Dividend Information - Novo Nordisk currently pays a dividend of $0.82 per share, resulting in a dividend yield of 2.29% [3] - The company's annualized dividend of $1.64 has increased by 59.8% compared to the previous year [4] - Over the last five years, Novo Nordisk has raised its dividend five times, averaging an annual increase of 22.48% [4] - The current payout ratio is 48%, indicating that the company distributes 48% of its trailing 12-month earnings per share as dividends [4] Earnings Growth - The Zacks Consensus Estimate for Novo Nordisk's earnings in 2025 is projected at $3.84 per share, reflecting a year-over-year growth rate of 17.07% [5] Investment Considerations - Novo Nordisk is considered a strong dividend investment opportunity, especially as it is a more established company with secure profits [7] - The stock currently holds a Zacks Rank of 3 (Hold), suggesting a stable investment outlook [7]

Company Overview - Associated Banc-Corp (ASB) is headquartered in Green Bay and has experienced a price change of -3.05% this year [3] - The company currently pays a dividend of $0.23 per share, resulting in a dividend yield of 3.97%, which is higher than the Banks - Midwest industry's yield of 3.13% and the S&P 500's yield of 1.57% [3] Dividend Performance - The current annualized dividend of $0.92 represents a 3.4% increase from the previous year [4] - Over the past five years, Associated Banc-Corp has increased its dividend four times, averaging an annual increase of 5.65% [4] - The company's payout ratio is currently 41%, indicating that it pays out 41% of its trailing 12-month earnings per share as dividends [4] Earnings Growth Expectations - For the fiscal year, ASB anticipates solid earnings growth, with the Zacks Consensus Estimate for 2025 projected at $2.49 per share, reflecting a year-over-year growth rate of 4.62% [5] Investment Considerations - Associated Banc-Corp is viewed as a compelling investment opportunity due to its strong dividend profile and current Zacks Rank of 3 (Hold) [7]

McDonald's Corporation (NYSE: MCD ) is facing immediate pressure (investor caution wise) over the already sensitive discretionary spending cuts. While I always look at MCD as a defensive play in the retail segment, the macro headwinds are a risk that could impact upside potential forI am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth investmen ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Open Lending Corporation due to alleged violations of federal securities laws, with a deadline for investors to seek lead plaintiff status by June 30, 2025 [3][5]. Group 1: Allegations Against Open Lending - The complaint alleges that Open Lending and its executives made false or misleading statements and failed to disclose material adverse facts about the company's business and operations [5]. - Specific allegations include misrepresentation of the company's risk-based pricing models, misleading statements regarding profit share revenue, and failure to disclose the significant depreciation of 2021 and 2022 vintage loans [5]. - The company is accused of misrepresenting the underperformance of its 2023 and 2024 vintage loans, leading to materially misleading statements about its business prospects [5]. Group 2: Stock Price Impact - Following the announcement of a postponed earnings release on March 17, 2025, Open Lending's stock price fell by $0.40, or 9.3%, closing at $3.91 per share [7]. - On March 31, 2025, the company reported a significant year-over-year increase in net loss for Q4 2024, which contributed to a further decline in stock price [7]. - On April 1, 2025, Open Lending's stock price dropped by $1.59, or 57.61%, closing at $1.17 per share, indicating substantial investor injury [8]. Group 3: Legal Proceedings - The court-appointed lead plaintiff will be the investor with the largest financial interest in the relief sought, who will oversee the litigation on behalf of the class [9]. - Any member of the class can move to serve as lead plaintiff or remain an absent class member without affecting their ability to share in any recovery [9]. - Faruqi & Faruqi encourages individuals with information regarding Open Lending's conduct to come forward, including whistleblowers and former employees [10].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In NET Power To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in NET Power between June 9, 2023 and March 7, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Faruqi & ...

Core Insights - ExxonMobil Corporation (XOM) faced a setback in its low-carbon energy initiatives due to the U.S. Department of Energy's (DoE) decision to revoke over $3.7 billion in awards for green energy projects, including a $332 million grant for its Baytown complex project [1][9] Group 1: Government Actions - The Trump administration is reviewing and scaling back financial support for clean energy projects awarded under the Biden administration, focusing on maximizing oil and gas production while rolling back climate change policies [2] - The DoE's Office of Clean Energy Developments stated that the revoked projects, including ExxonMobil's, were commercially unviable and lacked proper financial review [4][9] Group 2: Environmental Impact - Environmental advocates criticized the funding cuts, warning that they could hinder progress toward clean energy and reduce industry competitiveness [5] - The Center for Climate and Energy Solutions estimated that the withdrawal of funding could result in the loss of 25,000 jobs and $4.6 billion in industrial output, as these projects were intended to be pilot initiatives for larger programs [6] Group 3: Company Position - ExxonMobil currently holds a Zacks Rank of 4 (Sell), indicating a less favorable investment outlook compared to other energy sector stocks like Flotek Industries, Energy Transfer, and RPC, which have better rankings [7]